Cancer Has No Gender: Challenging Assumptions and Improving Quality of Care for the LGBTQ+ CommunityDecember 7th 2022
Improve care for LGBTQ+ patients with cancer by learning about disparities, focusing on patient-centered treatment, and not making assumptions about patients and their loved ones.
Later Toxicities Linked to Bone Marrow Transplant Highlight Necessity of Thorough Survivorship Care for Patients With AMLOctober 14th 2022
Individuals with AML who underwent a bone marrow transplant are at an increased risk of developing subsequent neoplasms, and other chronic health conditions.
HER-2 Directed Therapies Making Waves in Early-Stage and Metastatic Breast CancerFebruary 17th 2022
A City of Hope expert underscores the benefit of using antibody-drug conjugates, CDK4/6 inhibitors, PARP inhibitors, and checkpoint blockade in early-stage and metastatic breast cancer.
Drug Duo Is Promising in Older Patients With Advanced HCCJuly 5th 2020
The combination of atezolizumab (Tecentriq) and bevacizumab (Avastin) demonstrated comparable clinical activity and safety versus sorafenib (Nexavar) in older and younger patients with previously untreated, unresectable hepatocellular carcinoma (HCC).